MedPath

comparing duration of phototherpy in neonatal jaundice between two different guidelines

Not Applicable
Completed
Conditions
Health Condition 1: null- icteric newborn
Registration Number
CTRI/2018/02/011940
Lead Sponsor
IPGMER Kolkata
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
130
Inclusion Criteria

All babies requiring phototherapy for neonatal hyperbilirubinemia between 35-42 weeks of gestational age will be included in the study.

Exclusion Criteria

a.Any baby having major congenital malformation

b.Babies with haemolytic jaundice

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome variable is duration of phototherapy.Timepoint: 6hrs,12hrs,24hrs,48hrs.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome variables are treatment failure and rebound <br/ ><br> <br/ ><br>hyperbilirubinemia.Timepoint: 6hrs,12 hrs,24 hrs,48 hrs
© Copyright 2025. All Rights Reserved by MedPath